Position: Chief Commercial Officer
Joined Alexion: 2006
Prior to Alexion: VP Sales at OSI Eyetech, Amgen, Biogen Idec
Education: BA from the University of New Hampshire
With more than 25 years of experience in the Biotechnology industry, Mr. Hallal joined Alexion in 2006 to spearhead the launch of Soliris for PNH at first in the US, then globally. Mr. Hallal is responsible for the all commercial function in the US, EMEA, Japan, Latin America and Australsia, and is currently leading a global team as they promote Soliris for its more recent indications.